BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil
(NASDAQ: BBIO) Delayed: 68.92 +2.65 (4.00%)
Previous Close $66.27    52 Week High $ 
Open $66.35    52 Week Low $ 
Day High $69.66    P/E N/A 
Day Low $66.30    EPS $ 
Volume 2,539,398